Mod­er­na goes on the patent of­fen­sive; Pablo Legor­re­ta dou­bles down; Is a biotech re­cov­ery on the way?; and more

Wel­come back to End­points Week­ly, your re­view of the week’s top bio­phar­ma head­lines. Want this in your in­box every Sat­ur­day morn­ing? Cur­rent End­points read­ers can vis­it their read­er pro­file to add End­points Week­ly. New to End­points? Sign up here.

An­oth­er round of ma­jor med­ical con­fer­ences is up­on us, and Kyle LaHu­cik is in Barcelona, bring­ing us live cov­er­age from the Eu­ro­pean So­ci­ety of Car­di­ol­o­gy Con­gress. We’ll be post­ing up­dates on our web­site through­out the week­end.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER